Skip to main content
Top
Published in: Drugs & Aging 1/2005

01-01-2005 | Original Research Article

The Association of Inappropriate Drug Use with Hospitalisation and Mortality

A Population-Based Study of the Very Old

Authors: Dr Inga Klarin, Anders Wimo, Johan Fastbom

Published in: Drugs & Aging | Issue 1/2005

Login to get access

Abstract

Background and objective

Inappropriate prescribing is an important and possibly preventable risk factor for adverse drug reactions (ADRs) in the elderly, and hospital-based studies have shown that a large proportion of admissions is a result of ADRs. However, little is known about how inappropriate drug use (IDU) affects the elderly at the population level. The aim of this study was to explore possible associations of IDU with acute hospitalisation and mortality in an elderly population during 3 years of follow-up.

Patients and methods

Data from a rural, population-based, longitudinal cohort study within the Kungsholmen Project, Sweden, were used. 785 participants, ≥75 years of age, had complete data on drug use and selected covariates collected during baseline investigation from 1995 to 1998, and were included in the study. Hospitalisation and mortality data during 3 years after inclusion were collected. IDU was assessed at baseline using consensus-based criteria applicable to available data (derived from Beers’ criteria, Canadian criteria and clinical indicators of drug-related morbidity in older adults) with the addition of potentially dangerous drug duplication and additional potentially hazardous drug-drug interactions. IDU was defined as presence of at least one inappropriate drug regimen according to the study criteria. Logistic regression and proportional hazard models were used, respectively, to study the association of IDU with hospitalisation and mortality.

Results

Drugs were used on a regular or ‘as needed’ basis by 91.6% of the study population, with a mean of 4.4 drugs per person. IDU was common, with a prevalence of 18.6% and was associated with increased risk of at least one acute hospitalisation in community-living elderly, after adjustment for age, sex, education, comorbidity, dependency in activities of daily living (ADL) and smoking. The odds ratio was 2.72 (95% CI 1.64, 4.51). No association with mortality was found, after adjustment for age, sex, housing, education, comorbidity, ADL-dependency, smoking and body mass index.

Conclusion

Polypharmacy and IDU are common among the elderly and IDU is associated with acute hospitalisation in community-living elderly. Although causality cannot be established with this study design, the results are consistent with the high prevalence of drug-related hospital admissions found in hospital-based studies. Our results indicate that it is desirable with current knowledge, to reduce IDU through information to physicians and careful prescribing.
Footnotes
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literature
1.
go back to reference Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 2: 294–300 Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 2: 294–300
2.
go back to reference Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000 Mar; 34: 338–46PubMed Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000 Mar; 34: 338–46PubMed
3.
go back to reference Giron MST, Wang HX, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriate Soc 2001; 49(3): 277–83 Giron MST, Wang HX, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriate Soc 2001; 49(3): 277–83
4.
go back to reference Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriate Soc 2002; 50(1): 26–34 Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriate Soc 2002; 50(1): 26–34
5.
go back to reference Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002; 42(6): 847–57 Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002; 42(6): 847–57
6.
go back to reference Beijer HJM, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46–54PubMed Beijer HJM, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46–54PubMed
7.
go back to reference Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14(2): 141–52PubMed Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14(2): 141–52PubMed
8.
go back to reference Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging 1994; 4(6): 449–61PubMed Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging 1994; 4(6): 449–61PubMed
9.
go back to reference Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195–200PubMed Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195–200PubMed
10.
go back to reference Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997; 87(3): 404–9PubMedPubMedCentral Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997; 87(3): 404–9PubMedPubMedCentral
11.
go back to reference Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315(7115): 1096–9PubMedPubMedCentral Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315(7115): 1096–9PubMedPubMedCentral
12.
go back to reference Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001; 250: 327–41PubMed Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001; 250: 327–41PubMed
13.
go back to reference Shelton PS, Fritsch MA, Scott MA. Assessing medication appropriateness in the elderly: a review of available measures. Drugs Aging 2000; 16(6): 437–50PubMed Shelton PS, Fritsch MA, Scott MA. Assessing medication appropriateness in the elderly: a review of available measures. Drugs Aging 2000; 16(6): 437–50PubMed
14.
go back to reference Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002; 40(2): 166–76PubMed Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002; 40(2): 166–76PubMed
15.
go back to reference Fillenbaum GG, Hanlon JT, Landerman LR, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriate Pharmacother 2004; 2(2): 92–101 Fillenbaum GG, Hanlon JT, Landerman LR, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriate Pharmacother 2004; 2(2): 92–101
16.
go back to reference Gupta S, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clin Ther 1996; 18(1): 183–96PubMed Gupta S, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clin Ther 1996; 18(1): 183–96PubMed
17.
go back to reference Chin MH, Wang LC, Jin L, et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6(12): 1232–42PubMed Chin MH, Wang LC, Jin L, et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6(12): 1232–42PubMed
18.
go back to reference Aparasu RR, Mort JR. Prevalence, correlates and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriate Pharmacother 2004; 2(2): 102–11 Aparasu RR, Mort JR. Prevalence, correlates and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriate Pharmacother 2004; 2(2): 102–11
19.
go back to reference Fu AZ, Liu GG, Christensen DB. Inappropriate medication use and health outcomes in the elderly. J Am Geriate Soc 2004; 52(11) 1934–9 Fu AZ, Liu GG, Christensen DB. Inappropriate medication use and health outcomes in the elderly. J Am Geriate Soc 2004; 52(11) 1934–9
20.
go back to reference Fratiglioni L, Viitanen M, Backman L, et al. Occurrence of dementia in advanced age: the study design of the Kung-sholmen Project. Neuroepidemiology 1992; 11Suppl. 1: 29–36PubMed Fratiglioni L, Viitanen M, Backman L, et al. Occurrence of dementia in advanced age: the study design of the Kung-sholmen Project. Neuroepidemiology 1992; 11Suppl. 1: 29–36PubMed
21.
go back to reference Klarin I, Fastbom J, Wimo A. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Saf 2003; 12: 669–78PubMed Klarin I, Fastbom J, Wimo A. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Saf 2003; 12: 669–78PubMed
22.
go back to reference WHO Collaborating Centre for Drug Statistics and Methodology. Guidelines for ATC classification and DDD assignment. Oslo, Norway: World Health Organization, 1995 WHO Collaborating Centre for Drug Statistics and Methodology. Guidelines for ATC classification and DDD assignment. Oslo, Norway: World Health Organization, 1995
23.
go back to reference Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997 Jul 28; 157: 1531–6PubMed Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997 Jul 28; 157: 1531–6PubMed
24.
go back to reference McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156(3): 385–91PubMedPubMedCentral McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156(3): 385–91PubMedPubMedCentral
25.
go back to reference Robertson HA, MacKinnon NJ. Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002; 24(10): 1595–613PubMed Robertson HA, MacKinnon NJ. Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002; 24(10): 1595–613PubMed
26.
go back to reference Sjöqvist F. Drug interactions [in Swedish]. In: FASS. Läkemedel i Sverige. Forteckning over humanläkemedel. Stockholm, Sweden: LINFO Läkemedelsinformation AB, 1997: 1220–73 Sjöqvist F. Drug interactions [in Swedish]. In: FASS. Läkemedel i Sverige. Forteckning over humanläkemedel. Stockholm, Sweden: LINFO Läkemedelsinformation AB, 1997: 1220–73
27.
go back to reference Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic meta-analysis. I: psychotropic drugs. J Am Geriate Soc 1999; 47(1): 30–9 Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic meta-analysis. I: psychotropic drugs. J Am Geriate Soc 1999; 47(1): 30–9
28.
go back to reference Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15(1): 15–28PubMed Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15(1): 15–28PubMed
29.
go back to reference Miller EA, Weissert WG. Predicting elderly people’s risk for nursing home placement, hospitalization, functional impairment, and mortality: a synthesis. Med Care Res Rev 2000, 97 Miller EA, Weissert WG. Predicting elderly people’s risk for nursing home placement, hospitalization, functional impairment, and mortality: a synthesis. Med Care Res Rev 2000, 97
30.
go back to reference Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83PubMed Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83PubMed
31.
go back to reference Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45(6): 613–9PubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45(6): 613–9PubMed
32.
go back to reference Buntinx F, Niclaes L, Suetens C, et al. Evaluation of Charlson’s comorbidity index in elderly living in nursing homes. J Clin Epidemiol 2002; 55: 1144–7PubMed Buntinx F, Niclaes L, Suetens C, et al. Evaluation of Charlson’s comorbidity index in elderly living in nursing homes. J Clin Epidemiol 2002; 55: 1144–7PubMed
33.
go back to reference Bravo G, Dubois MF, Réjean H, et al. A prospective evaluation of the Charlson comorbidity index for use in long-term care patients. J Am Geriate Soc 2002; 50(4): 740–5 Bravo G, Dubois MF, Réjean H, et al. A prospective evaluation of the Charlson comorbidity index for use in long-term care patients. J Am Geriate Soc 2002; 50(4): 740–5
34.
go back to reference Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41PubMed Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41PubMed
35.
go back to reference Jassal V, Fillit H, Oreopoulos DG. Diseases of the aging kidney. In: Tallis R, Fillit H, Brocklehurst JC, editors. Brocklehurst’s textbook of geriatric medicine and gerontology. 5th ed. London: Churchill Livingstone, 1998: 949–71 Jassal V, Fillit H, Oreopoulos DG. Diseases of the aging kidney. In: Tallis R, Fillit H, Brocklehurst JC, editors. Brocklehurst’s textbook of geriatric medicine and gerontology. 5th ed. London: Churchill Livingstone, 1998: 949–71
36.
go back to reference Flodin L, Svensson S, Cederholm T. Body mass index as a predictor of 1 year mortality in geriatric patients. Clin Nutr 2000; 19(2): 121–5PubMed Flodin L, Svensson S, Cederholm T. Body mass index as a predictor of 1 year mortality in geriatric patients. Clin Nutr 2000; 19(2): 121–5PubMed
37.
go back to reference Grabowski DC, Ellis JE. High body mass index does not predict mortality in older people: analysis of the longitudinal study of aging. J Am Geriate Soc 2001; 49(7): 968–79 Grabowski DC, Ellis JE. High body mass index does not predict mortality in older people: analysis of the longitudinal study of aging. J Am Geriate Soc 2001; 49(7): 968–79
38.
go back to reference Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185(12): 914–9PubMed Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185(12): 914–9PubMed
39.
go back to reference Jörgensen TM, Isacsson DGL, Thorslund M. Prescription drug use among ambulantory eldery in a Swedish municipality. Ann Pharmacother 1993 Sep; 27: 1120–5PubMed Jörgensen TM, Isacsson DGL, Thorslund M. Prescription drug use among ambulantory eldery in a Swedish municipality. Ann Pharmacother 1993 Sep; 27: 1120–5PubMed
40.
go back to reference Chen Y-F, Dewey ME, Avery AJ, et al. Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 2001; 26: 129–40PubMed Chen Y-F, Dewey ME, Avery AJ, et al. Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 2001; 26: 129–40PubMed
41.
go back to reference Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES project. Ann Pharmacother 1996 Jun; 30: 589–95PubMed Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES project. Ann Pharmacother 1996 Jun; 30: 589–95PubMed
43.
go back to reference Table 60: population by sex, marital status and age by single years. In: Statistical yearbook of Sweden. Örebro, Sweden: Statistics Sweden, 2000: 57–8 Table 60: population by sex, marital status and age by single years. In: Statistical yearbook of Sweden. Örebro, Sweden: Statistics Sweden, 2000: 57–8
44.
45.
go back to reference Piecoro LT, Browning SR, Prince TS, et al. A database analysis of potentially inappropriate drug use in an elderly Medicaid population. Pharmacotherapy 2000; 20(2): 221–8PubMed Piecoro LT, Browning SR, Prince TS, et al. A database analysis of potentially inappropriate drug use in an elderly Medicaid population. Pharmacotherapy 2000; 20(2): 221–8PubMed
46.
go back to reference Dhalla IA, Anderson GM, Mamdani MM, et al. Inappropriate prescribing before and after nursing home admission. J Am Geriate Soc 2002; 50(6): 995–1000 Dhalla IA, Anderson GM, Mamdani MM, et al. Inappropriate prescribing before and after nursing home admission. J Am Geriate Soc 2002; 50(6): 995–1000
47.
go back to reference Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy 2000; 20(5): 575–82PubMed Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy 2000; 20(5): 575–82PubMed
48.
go back to reference Stuart B, Coulson NE. Dynamic aspects of prescription drug use in an elderly population. Health Serv Res 1993; 28: 237–64PubMedPubMedCentral Stuart B, Coulson NE. Dynamic aspects of prescription drug use in an elderly population. Health Serv Res 1993; 28: 237–64PubMedPubMedCentral
49.
go back to reference Garrard J, Dunham T, Makris L, et al. Longitudinal study of psychotropic drug use by elderly nursing home residents. J Gerontol 1992; 47(6): M183–8PubMed Garrard J, Dunham T, Makris L, et al. Longitudinal study of psychotropic drug use by elderly nursing home residents. J Gerontol 1992; 47(6): M183–8PubMed
50.
go back to reference Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriate Soc 2001; 49(2): 200–9 Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriate Soc 2001; 49(2): 200–9
Metadata
Title
The Association of Inappropriate Drug Use with Hospitalisation and Mortality
A Population-Based Study of the Very Old
Authors
Dr Inga Klarin
Anders Wimo
Johan Fastbom
Publication date
01-01-2005
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 1/2005
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200522010-00005

Other articles of this Issue 1/2005

Drugs & Aging 1/2005 Go to the issue

Adis Drug Profile

Rasagiline

Adis Drug Profile

Rasagiline

Adis Drug Profile

Rasagiline

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.